Compare Marqeta Inc (MQ) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marqeta Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Marqeta Inc trades at $18.85 (market cap $1.89B), while Vir Biotechnology Inc. Common Stock trades at $10.52 (market cap $1.76B). The key difference: Marqeta Inc and Vir Biotechnology Inc. Common Stock are close in size by market cap, and Marqeta Inc is more actively traded (809,068 versus 2,764,948). Which is the better fit depends on your goals — on Pluang, investors hold Marqeta Inc for 44 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| MQ | VIR | |
|---|---|---|
Market Cap | $1.89B | $1.76B |
Volume | 809,068 | 2,764,948 |
Sector | Technology | Health |
52-Week High | $20.32 | $11.78 |
52-Week Low | $15.04 | $5.12 |
Typical Hold Time | 44 Days | 0 Days |
Enterprise Value | $1.21B | $1.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marqeta (MQ) trades at $18.56, up 1.48% today, with a bullish technical signal and strong earnings beats in recent quarters. The company reported revenue of $624.88 million in 2025, with a net loss of $13.93 million, but forecasts show improving profitability in 2026. Recent news highlights partnerships with BVNK for stablecoin cards and expansion with Google Wallet, signaling growth initiatives.
Outlook is mixed: bullish technicals and positive earnings momentum contrast with high valuation multiples (P/E 202) and analyst caution (31.8% buy rating). Key risks include contract renewals in Q3 2026 and competitive pressures in fintech. Upside potential exists if earnings growth continues, but investors should weigh high valuation against execution risks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Marqeta Inc
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
